Concurrent pathogenic variants in SLC6A1/NOTCH1/PRIMPOL genes in a Chinese patient with myoclonic-atonic epilepsy, mild aortic valve stenosis and high myopia.
Aortic Valve Stenosis
/ genetics
Child, Preschool
DNA Primase
/ genetics
DNA-Directed DNA Polymerase
/ genetics
Epilepsies, Myoclonic
/ genetics
Epilepsy, Generalized
/ genetics
GABA Plasma Membrane Transport Proteins
/ genetics
Genetic Predisposition to Disease
Genetic Testing
Humans
Intellectual Disability
/ genetics
Male
Multifunctional Enzymes
/ genetics
Mutation
/ genetics
Myopia
/ genetics
Receptor, Notch1
/ genetics
Exome Sequencing
High myopia
Myoclonic-atonic epilepsy
NOTCH1
PRIMPOL
SLC6A1
Whole-exome sequencing
Journal
BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552
Informations de publication
Date de publication:
06 05 2020
06 05 2020
Historique:
received:
08
04
2020
accepted:
27
04
2020
entrez:
8
5
2020
pubmed:
8
5
2020
medline:
17
7
2020
Statut:
epublish
Résumé
Pathogenic SLC6A1 variants have been reported in patients with myoclonic-atonic epilepsy (MAE). NOTCH1, encoding a member of the Notch family of proteins, is known to be associated with aortic valve disease. The PRIMPOL variant has only been identified in Chinese patients with high myopia. Exome sequencing analysis now allows the simultaneous detection of multiple genetic etiologies for patients with complicated clinical features. However, the presence of three Mendelian disorders in one patient supported by their respective pathogenic variants and clinical phenotypes is very rare. Here, we report a 4-year-old Chinese boy who presented with MAE, delayed language, borderline intellectual disability (ID), mildly impaired social skills and attention deficit hyperactivity disorder (ADHD). He also had mild aortic valve stenosis and high myopia. Using whole-exome sequencing (WES), we identified three variants: (1) SLC6A1, NM_003042.4: c.881-883del (p.Phe294del), (2) NOTCH1, NM_017617.5:c.1100-2A > G and (3) PRIMPOL, NM_152683.4:c.265 T > G (p.Tyr89Asp). Parental Sanger sequencing confirmed that SLC6A1 and NOTCH1 variants were de novo, whereas the PRIMPOL variant was inherited from the father who also had high myopia. Furthermore, the PRIMPOL variant was absent from the genomes of the paternal grandparents, and thus was also a de novo event in the family. All three variants are classified as pathogenic. The SLC6A1 variant could explain the features of MAE, delayed language, borderline ID, impaired social skills and ADHD in this patient, whereas the features of aortic valve stenosis and high myopia of the patient may be explained by variants in NOTCH1 and PRIMPOL, respectively. This case demonstrated the utility of exome sequencing in uncovering the multiple pathogenic variants in a patient with complicated phenotypes due to the blending of three Mendelian disorders.
Sections du résumé
BACKGROUND
Pathogenic SLC6A1 variants have been reported in patients with myoclonic-atonic epilepsy (MAE). NOTCH1, encoding a member of the Notch family of proteins, is known to be associated with aortic valve disease. The PRIMPOL variant has only been identified in Chinese patients with high myopia. Exome sequencing analysis now allows the simultaneous detection of multiple genetic etiologies for patients with complicated clinical features. However, the presence of three Mendelian disorders in one patient supported by their respective pathogenic variants and clinical phenotypes is very rare.
CASE PRESENTATION
Here, we report a 4-year-old Chinese boy who presented with MAE, delayed language, borderline intellectual disability (ID), mildly impaired social skills and attention deficit hyperactivity disorder (ADHD). He also had mild aortic valve stenosis and high myopia. Using whole-exome sequencing (WES), we identified three variants: (1) SLC6A1, NM_003042.4: c.881-883del (p.Phe294del), (2) NOTCH1, NM_017617.5:c.1100-2A > G and (3) PRIMPOL, NM_152683.4:c.265 T > G (p.Tyr89Asp). Parental Sanger sequencing confirmed that SLC6A1 and NOTCH1 variants were de novo, whereas the PRIMPOL variant was inherited from the father who also had high myopia. Furthermore, the PRIMPOL variant was absent from the genomes of the paternal grandparents, and thus was also a de novo event in the family. All three variants are classified as pathogenic.
CONCLUSION
The SLC6A1 variant could explain the features of MAE, delayed language, borderline ID, impaired social skills and ADHD in this patient, whereas the features of aortic valve stenosis and high myopia of the patient may be explained by variants in NOTCH1 and PRIMPOL, respectively. This case demonstrated the utility of exome sequencing in uncovering the multiple pathogenic variants in a patient with complicated phenotypes due to the blending of three Mendelian disorders.
Identifiants
pubmed: 32375772
doi: 10.1186/s12881-020-01035-9
pii: 10.1186/s12881-020-01035-9
pmc: PMC7203802
doi:
Substances chimiques
GABA Plasma Membrane Transport Proteins
0
Multifunctional Enzymes
0
NOTCH1 protein, human
0
Receptor, Notch1
0
SLC6A1 protein, human
0
DNA Primase
EC 2.7.7.-
PrimPol protein, human
EC 2.7.7.-
DNA-Directed DNA Polymerase
EC 2.7.7.7
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
93Subventions
Organisme : Dongguan Social development project
ID : 201950715007158
Pays : International
Références
Biochim Biophys Acta. 2016 Apr;1862(4):733-740
pubmed: 26876948
Genet Med. 2019 Nov;21(11):2413-2421
pubmed: 31182824
Genet Med. 2016 Jul;18(7):746-9
pubmed: 26716362
Hum Mol Genet. 2008 Sep 15;17(18):2886-93
pubmed: 18593716
Brain Res Mol Brain Res. 1995 Oct;33(1):7-21
pubmed: 8774941
Epilepsia. 2018 Feb;59(2):389-402
pubmed: 29315614
Nature. 2005 Sep 8;437(7056):270-4
pubmed: 16025100
Nucleic Acids Res. 2014 Oct 29;42(19):12102-11
pubmed: 25262353
Epilepsia. 2018 Sep;59(9):e135-e141
pubmed: 30132828
N Engl J Med. 2017 Jan 5;376(1):21-31
pubmed: 27959697
Neurogenetics. 2017 Dec;18(4):195-205
pubmed: 28849312
J Biol Chem. 2004 Jul 16;279(29):30771-80
pubmed: 15123653
Genet Med. 2019 Jun;21(6):1443-1451
pubmed: 30377382
Hum Genet. 2013 Aug;132(8):913-21
pubmed: 23579484
Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
Am J Hum Genet. 2015 May 7;96(5):808-15
pubmed: 25865495
Biochem Biophys Res Commun. 2006 Jul 14;345(4):1460-5
pubmed: 16729972
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Pediatr Neurol. 2016 Nov;64:77-79
pubmed: 27600546
Invest Ophthalmol Vis Sci. 2015 Feb 13;56(2):1183
pubmed: 25680976
Invest Ophthalmol Vis Sci. 2015 Feb 13;56(2):1181-2
pubmed: 25680975
Genet Med. 2016 Sep;18(9):914-23
pubmed: 26820064
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:202-208
pubmed: 28442423